CoChat

Glucocorticoids and the Th1/Th2 Balance

· 2004 · Hormone and Metabolic Research
Cited by 42

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

I. J. Elenkov Clinical Neuroendocrinology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, U.S.A. Immune responses are regulated by antigen-presenting cells (APC) -monocytes/macrophages and dendritic cells, and by natural killer (NK) cells that are components of innate immunity , and by the recently described T helper (Th) lymphocyte subclasses Th1 and Th2, that are components of adaptive ( acquired ) immunity. Th1 cells primarily secrete IFN-γ, IL-2 and TNFβ, which promote cellular immunity, whereas Th2 cells secrete a different set of cytokines, primarily IL-4, IL-10 and IL-13 which promote humoral immunity. Naive CD4 + (antigen-inexperienced) Th0 cells are clearly bipotential and serve as precursors of Th1 and Th2 cells. Among the factors currently known to influence the differentiation of these cells towards Th1 or Th2, cytokines produced by cells of the innate immune system are the most important. Thus, IL-12, produced by activated monocytes/macrophages or other APCs, is a major inducer of Th1 differentiation and hence cellular immunity. This cytokine acts in concert with NK-derived IFN-γ to further promote Th1 responses. APC-derived IL-12 and TNFα in concert with natural killer (NK) cell and Th1-derived IFN-γ stimulate the functional activity of T cytotoxic cells (Tc), NK cells and activated macrophages, which are the major components of cellular immunity. The type 1 cytokines IL-12, TNFα and IFN-γ also stimulate the synthesis of nitric oxide (NO) and other inflammatory mediators that drive chronic delayed type inflammatory responses. Because of these crucial and synergistic roles in inflammation IL-12, TNFα and IFN-γ are considered the major pro-inflammatory cytokines. Th1 and Th2 responses are mutually inhibitory. Thus, IL-12 and IFN-γ inhibit Th2 cells activities, while IL-4 and IL-10 inhibit Th1 responses. IL-4 and IL-10 promote humoral immunity by stimulating the growth and activation of mast cells and eosinophils, the differentiation of B cells into antibody-secreting B cells, and B cell immunoglobulin switching to IgE. Importantly, these cytokines also inhibit macrophage activation, T-cell proliferation and the production of pro-inflammatory cytokines. Therefore, the Th2 (type 2) cytokines IL-4 and IL-10 are the major anti-inflammatory cytokines. Previous studies have shown that glucocorticoids suppress the production of TNFα, IFN-γ and IL-2 in vitro and in vivo in animals and humans. These early observations, in the context of the broad clinical use of glucocorticoids, initially led to the conclusion that stress hormones are, in general, immunosuppressive. Recent evidence indicates, however, that systemically, glucocorticoids cause selective suppression of Th1 responses and a shift towards Th2-mediated humoral immunity, rather than generalized immunosuppression. Thus, recent evidence indicates that glucocorticoids also act through their classic cytoplasmic/nuclear receptors on APCs to suppress the production of the main inducer of Th1 responses IL-12 in vitro and ex vivo . Since IL-12 is extremely potent in enhancing IFN-γ and inhibiting IL-4 synthesis by T cells, the inhibition of IL-12 production by APCs may represent a major mechanism by which glucocorticoids affect the Th1/Th2 balance. Thus, glucocorticoid-treated monocytes/macrophages produce significantly less IL-12, leading to their decreased capacity to induce IFN-γ production by antigen-primed CD4 + T cells. This is also associated with an increased production of IL-4 by T cells, probably resulting from disinhibition from the suppressive effects of IL-12 on Th2 activity. Furthermore, glucocorticoids potently downregulate the expression of IL-12 receptors on T and NK cells. This explains why human peripheral blood mononuclear cells (PBMCs) stimulated with immobilized anti-CD3 lose their ability to produce IFN-γ in the presence of glucocorticoids. Thus, although glucocorticoids may have a direct suppressive effect on Th1 cells, the overall inhibition of IFN-γ production by these cells appears to result mainly from the inhibition of IL-12 production by APCs and from the loss of IL-12 responsiveness of NK and Th1 cells. It is particularly noteworthy that glucocorticoids have no effect on the production of the potent anti-inflammatory cytokine IL-10 by monocytes; yet, lymphocyte-derived IL-10 production appears to be upregulated by glucocorticoids. Thus, rat CD4 + T cells pretreated with dexamethasone exhibit increased levels of mRNA for IL-10. Similarly, during experimental endotoxemia or cardiopulmonary bypass, or in multiple sclerosis patients having an acute relapse, treatment with glucocorticoids is associated with increased plasma IL-10 secretion. This could be the result of a direct stimulatory effect of glucocorticoids on T cell IL-10 production and/or a block on the restraining inputs of IL-12 and IFN-γ on monocyte/lymphocyte IL-10 production. In contrast to catecholamines, glucocorti

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-2003-43512-15

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 42

Metadata

Venue
Hormone and Metabolic Research
Published
2004-04-29
Volume
35
Issue
10
Pages
628-648
ISSN
  • 0018-5043 (ISSN-L)
  • 1439-4286
OpenAlex
W4246822264
Cited by
42
References
6
FWCI
0.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucocorticoids and the Th1/Th2 Balance. https://app.cochat.ai/papers/10.1055/s-2003-43512-15
The paper
Glucocorticoids and the Th1/Th2 Balance. (2004). Hormone and Metabolic Research. https://doi.org/10.1055/s-2003-43512-15

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.